Top Employee-Paid Stories
House advances bill to restrict Chinese biotech firms, but how will U.S. fill the void?
By Alan GoforthA House Committee approved the Biosecure Act to end U.S. contracting with Chinese firms deemed a threat to national security, but filling the void left by Chinese companies may be a challenge to U.S. drug development.










